Northwest & Ethical Investments’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-70,325
| Closed | -$2.16M | – | 397 |
|
|
2023
Q3 | $2.16M | Hold |
70,325
| – | – | 0.07% | 228 |
|
|
2023
Q2 | $2.82M | Sell |
70,325
-34,606
| -33% | -$1.39M | 0.09% | 223 |
|
|
2023
Q1 | $4.28M | Sell |
104,931
-1,656
| -2% | -$67.6K | 0.14% | 185 |
|
|
2022
Q4 | $4.12M | Buy |
106,587
+11,193
| +12% | +$432K | 0.14% | 189 |
|
|
2022
Q3 | $5.07M | Hold |
95,394
| – | – | 0.2% | 150 |
|
|
2022
Q2 | $5.56M | Buy |
95,394
+5,092
| +6% | +$297K | 0.21% | 141 |
|
|
2022
Q1 | $6.89M | Buy |
90,302
+54,720
| +154% | +$4.18M | 0.22% | 126 |
|
|
2021
Q4 | $2.14M | Buy |
+35,582
| New | +$2.14M | 0.06% | 235 |
|